Cargando…

P443: A POOLED FOCUSED IN VIVO CRISPR-CAS9 SCREENING IN IMMUNOCOMPETENT MICE ALLOWS IDENTIFICATION OF IMMUNE CHECKPOINTS RELEVANT FOR LEUKEMIC STEM CELLS

Detalles Bibliográficos
Autores principales:	Bachmann, Chantal, Forster, Stefan, Ochsenbein, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428790/ http://dx.doi.org/10.1097/01.HS9.0000968680.31930.2b

Ejemplares similares

CRISPR/Cas-based customization of pooled CRISPR libraries
por: Kweon, Jiyeon, et al.
Publicado: (2018)

443 Team Science
por: Miah, Sayem, et al.
Publicado: (2023)

SAT443 Prevalence Of Immune Checkpoint Inhibitor-related Endocrinopathies In Patients With Cancers
por: Pittampalli, Shanti, et al.
Publicado: (2023)

Special focus CRISPR-Cas
por: Marchfelder, Anita
Publicado: (2013)

CRISPR-Cas: biology, mechanisms and relevance
por: Hille, Frank, et al.
Publicado: (2016)

Tracheostomy in the ICU: an analysis of 443 procedures
por: Marbán, A, et al.
Publicado: (2009)

SUN-443 Surgical Management of Cystic Prolactinomas
por: Nevzati, Edin, et al.
Publicado: (2019)

CRISPR-Cas9 Mediated Labelling Allows for Single Molecule Imaging and Resolution
por: Khan, Abdullah O., et al.
Publicado: (2017)

Increasing the performance of pooled CRISPR–Cas9 drop-out screening
por: Cross, Benedict C. S., et al.
Publicado: (2016)

Regulation of hematopoietic and leukemic stem cells by the immune system
por: Riether, C, et al.
Publicado: (2015)

443 Non-Typhoidal Salmonella Infections in Cancer Patients
por: Mori, Nobuyoshi, et al.
Publicado: (2014)

P802: CD70/CD27 SIGNALING PROMOTES THE EXPANSION OF CLONAL PLASMA CELL SUBSETS IN MULTIPLE MYELOMA
por: Forster, Stefan, et al.
Publicado: (2023)

443. West Nile Virus in Humans in Greece, 2010–2017
por: Pervanidou, Danai, et al.
Publicado: (2018)

MON-443 Periostin Concentrations in Childhood-Onset Craniopharyngioma Patients
por: Heinks, Kerstin, et al.
Publicado: (2019)

THU443 Acute Iridocyclitis Associated With Intravenous Zoledronic Acid
por: Ankireddypalli, Anvitha Reddy, et al.
Publicado: (2023)

Induction of an immortalized songbird cell line allows for gene characterization and knockout by CRISPR-Cas9
por: Biegler, Matthew T., et al.
Publicado: (2022)

P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.
por: Albinger, Nawid, et al.
Publicado: (2023)

A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9
por: Dagdas, Yavuz S., et al.
Publicado: (2017)

CRISPR/Cas9-Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML
por: Vuelta, Elena, et al.
Publicado: (2022)

M4.4.3 Annual EuroNNAc workshop 2012
por: Assmann, R
Publicado: (2012)

PM443. The ECT Augmenting Effects for Patients with Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2016)

P452: CD4+ T CELLS REDUCE THE POPULATION OF LEUKEMIC STEM CELLS IN ACUTE MYELOID LEUKEMIA
por: Schnüriger, Noah, et al.
Publicado: (2023)

Pooled clone collections by multiplexed CRISPR-Cas12a-assisted gene tagging in yeast
por: Buchmuller, Benjamin C., et al.
Publicado: (2019)

Generation of a multiplex mutagenesis population via pooled CRISPR‐Cas9 in soya bean
por: Bai, Mengyan, et al.
Publicado: (2019)

CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells
por: Mohammadian Gol, Tahereh, et al.
Publicado: (2023)

Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
por: Kenjo, Eriya, et al.
Publicado: (2021)

Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage
por: Riesenberg, Stephan, et al.
Publicado: (2022)

Genetic barcodes allow traceability of CRISPR/Cas9-derived Aspergillus niger strains without affecting their fitness
por: Garrigues, Sandra, et al.
Publicado: (2021)

CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model
por: Felce, Suet Ling, et al.
Publicado: (2020)

Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation
por: Lin, Shan, et al.
Publicado: (2016)

An interactive web application for processing, correcting, and visualizing genome-wide pooled CRISPR-Cas9 screens
por: Vinceti, Alessandro, et al.
Publicado: (2023)

CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells
por: Kamali, Elahe, et al.
Publicado: (2021)

CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
por: Rahman, Mujeeb ur, et al.
Publicado: (2022)

Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy
por: Lim, Kenji Rowel Q., et al.
Publicado: (2018)

Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA
por: Liu, Mu-Sen, et al.
Publicado: (2020)

Evolution of giant pandoravirus revealed by CRISPR/Cas9
por: Bisio, Hugo, et al.
Publicado: (2023)

443 Immunoreactivity of ß-Lactoglobulin and Identification of the Peptides Generated after Simulated Orogastrointestinal Digestion
por: Benedé, Sara, et al.
Publicado: (2012)

SLC6A1 G443D associated with developmental delay and epilepsy
por: Devries, Seth, et al.
Publicado: (2020)

443. Do people living with HIV lose weight on GLP-1 agonist therapy?
por: Tauhid, Lamiya, et al.
Publicado: (2022)

FRI443 Optimizing Conditions Of Tubule-like Structures In Testicular Organoids That Will Support Spermatogenesis
por: Printy, Olivia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3qp9465albhdlbbgpu2sq68u5k